Cannabis Provider to Debut Five More Dispensaries in Florida

November 29, 2018

By The Life Science Report

Source: Streetwise Reports   11/26/2018

This company plans to add even more this year as well.

Liberty Health Sciences Inc. (LHS:CSE) will open five new cannabis dispensaries in Florida by year-end 2018, each with local 24-hour delivery service, it announced in a news release. The dispensaries will offer pharmaceutical-grade cannabis products, educational tools and individual informational consultations.

The locations launching by the end of November are Miami and Dania Beach. The three debuting before the end of December are Hollywood, Bonita Springs and Orange Park. The dispensaries’ hours will be 10 a.m. to 7 p.m. Monday through Friday, 10 a.m. to 5 p.m. Saturday, and noon to 5 p.m. Sunday.

Get our Weekly Commitment of Traders Report: - See where the biggest traders (Hedge Funds and Commercial Hedgers) are positioned in the futures markets on a weekly basis.

Get Our Free Metatrader 4 Indicators - Put Our Free MetaTrader 4 Custom Indicators on your charts when you join our Weekly Newsletter

“Liberty is now expanding exponentially and has become a formidable player in the Florida market,” CEO George Scorsis said in the release.

Liberty currently operates seven dispensaries and six delivery hubs throughout Florida; it intends to have 12 dispensaries by year-end, pending state Department of Health approval.

The company noted that it plans to increase its total cultivation space fo 225,000 square feet at its Gainesville facility.

Sign up for our FREE newsletter at:

1) Doresa Banning compiled this article for Streetwise Reports LLC and provides services to Streetwise reports as an independent contractor. She or members of her household own securities of the following companies mentioned in the article: None. She or members of her household are paid by the following companies mentioned in this article: None.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: None. Click here for important disclosures about sponsor fees.
3) Comments and opinions expressed are those of the specific experts and not of Streetwise Reports or its officers. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
4) The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article until three business days after the publication of the interview or article. The foregoing prohibition does not apply to articles that in substance only restate previously published company releases. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Liberty Health Sciences Inc., a company mentioned in this article.

( Companies Mentioned: LHS:CSE,